Bill
SB 161
Moves testing, labeling, and public health oversight of intoxicating cannabis products to CDPHE, with online safety data, seed-to-sale tracking, and registration for producers.
Purpose and intent
- Rebrands and reshapes Colorado’s regulation of cannabis-related products to emphasize consumer protection, public health, and consistent labeling.
- Moves testing, safety oversight, and product standards from the Department of Revenue to the Department of Public Health and Environment (CDPHE).
- Creates a unified framework for intoxicating cannabis products (including marijuana and intoxicating hemp) with a focus on labeling, testing, traceability, and online public access to product data.
Key provisions and changes
1) Tax structure and revenue stability
- Shifts marijuana tax policy to basis based on intoxicating cannabinoid content rather than price.
- Retains a tax framework that may not exceed 5 cents per milligram of total intoxicating cannabinoids for certain rates after 2030 (with a 2 cents/milligram cap before 2030).
- Establishes a legislative Council staff process to project and potentially adjust tax rates to stabilize revenue, including a sunset provision and annual inflation/deflation adjustments.
- Requires Joint Budget Committee consideration if adjustments are proposed.
2) Regulatory and agency realignment
- Transfers testing and safety elements from the Department of Revenue’s Marijuana Enforcement Division to CDPHE.
- Creates a new framework where:
- State Licensing Authority remains responsible for licensing, enforcement, and compliance.
- CDPHE handles testing standards, product safety, labeling standards, and health-focused oversight.
- An independent, referenced laboratory system will conduct mandatory testing and statewide off-shelf surveillance.
3) Registration and oversight of intoxicating cannabis producers
- Requires intoxicating cannabis producers to register with CDPHE (with a registration process and annual fees).
- Establishes penalties and enforcement mechanisms for noncompliance.
- Provides authority for ongoing inspection, testing, and corrective actions.
4) Public access and transparency
- Establishes an online portal to publicly display:
- Adverse health reports (with redacted customer data).
- Traceability information and testing results for intoxicating cannabis products available to consumers.
- Extends public access to include product batch data, manufacturers, cultivators, and retailers.
5) Seed-to-sale tracking and lab-testing framework
- Maintains seed-to-sale inventory tracking (for monitoring product movement and testing data).
- Requires reporting and access to testing results, with a plan for off-shelf surveillance testing.
- Introduces an authorized sampler system and requirements for sampling protocols, chain-of-custody, and testing standards.
6) Labeling, content claims, and enforcement
- Establishes labeling requirements for regulated marijuana and intoxicating hemp products, including:
- THC and other intoxicating cannabinoid milligrams per package and per serving.
- Total non-intoxicating cannabinoid milligrams.
- Warnings, universal cannabis symbol, and microbial contaminant limits.
- Provides penalties for labeling discrepancies or contamination, including possible recalls, quarantines, civil penalties, and possible license discipline.
7) Public health and consumer protection focus
- Consolidates health and safety oversight of consumable cannabis products within CDPHE.
- Emphasizes consumer access to safety data, accurate content claims, and robust testing practices.
8) Applicability and timeline
- Applies to conduct occurring on and after the act’s effective date.
- Includes references for potential voter consideration in the 2026 ballot and details for phased implementation (including timelines around registration and testing rules).
Potential impact
Note: This summary reflects the bill as introduced and may be amended.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
